URO TODAY: Statin use is associated with a decreased risk of prostate cancer diagnosis, a survey of nearly 2500 men found. READ MORE>
Archive for the ‘Cholesterol drugs’ Category
Men on cholesterol drugs have lower risk of prostate cancer
Posted in Cholesterol drugs, tagged cancer research, catheter, cholesterol, lowered prostate cancer risk, prostablog, prostate, prostate blog, PROSTATE CANCER, statins, URO TODAY on August 5, 2010 | Leave a Comment »
Get your cholesterol down if you want to avoid high-risk prostate cancer, another study finds
Posted in Cholesterol drugs, PROSTATE CANCER, PROSTATE RESEARCH, PROSTATE RISKS, tagged Baltimore, cancer research, catheter, Cholesterol levels, cholesterol-lowering, Johns Hopkins, prostate, prostate blog, PROSTATE CANCER, prostate-specific antigen, risk of high-grade prostate cancer, statins are protective on November 4, 2009 | Leave a Comment »
URO TODAY: Cholesterol levels and prostate cancer definitely seem to be conbnected, a new study at Johns Hopkins in Baltimore has revealed.
PROSTATE RESEARCH: Study will test if cholesterol/arthritis drugs combo treats cancer
Posted in Cholesterol drugs, New prostate drugs, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged arthritis pain drug, cancer research, cancer-killing drugs, Celebrex and Lipitor, celecoxib and atrovastatin, cholesterol-lowering drugs, nuclear factor kappa B (NFkB), prostablog, prostate, PROSTATE CANCER, prostate cancer treatments, prostate treatment, prostate treatment debate on April 29, 2009 | Leave a Comment »
Can combination therapy with Celebrex and Lipitor effectively treat patients with early-stage prostate cancer?
PROSTATE RESEARCH: Men on cholesterol drugs far less likely to develop cancer
Posted in Avoidance, Cholesterol drugs, PROSTATE CANCER, PROSTATE RESEARCH, tagged American Urological Association, cancer research, cholesterol, cholesterol-lowering drugs, Mayo Clinic, prostablog, prostate, PROSTATE CANCER, statins on April 27, 2009 | Leave a Comment »
Cholesterol-lowering statin drugs may protect men against prostate cancer and other urological complaints.









